期刊
NUCLEIC ACIDS RESEARCH
卷 37, 期 13, 页码 4420-4429出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkp399
关键词
-
资金
- National Institutes of Health/NCI [CA097175, CA093729]
- Howard Hughes Medical Institute
- NATIONAL CANCER INSTITUTE [R01CA093729, P01CA097175] Funding Source: NIH RePORTER
DNA interstrand crosslinks (ICLs) are among the most cytotoxic types of DNA damage, thus ICL-inducing agents such as psoralen, are clinically useful chemotherapeutics. Psoralen-modified triplex-forming oligonucleotides (TFOs) have been used to target ICLs to specific genomic sites to increase the selectivity of these agents. However, how TFO-directed psoralen ICLs (Tdp-ICLs) are recognized and processed in human cells is unclear. Previously, we reported that two essential nucleotide excision repair (NER) protein complexes, XPA-RPA and XPC-RAD23B, recognized ICLs in vitro, and that cells deficient in the DNA mismatch repair (MMR) complex MutS beta were sensitive to psoralen ICLs. To further investigate the role of MutS beta in ICL repair and the potential interaction between proteins from the MMR and NER pathways on these lesions, we performed electrophoretic mobility-shift assays and chromatin immunoprecipitation analysis of MutS beta and NER proteins with Tdp-ICLs. We found that MutS beta bound to Tdp-ICLs with high affinity and specificity in vitro and in vivo, and that MutS beta interacted with XPA-RPA or XPC-RAD23B in recognizing Tdp-ICLs. These data suggest that proteins from the MMR and NER pathways interact in the recognition of ICLs, and provide a mechanistic link by which proteins from multiple repair pathways contribute to ICL repair.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据